Antigen derivatives and processes for their preparation
US4397844A · kind A · utility
9Cited by
15References
24Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 17, 1981 |
| Grant date | Aug 9, 1983 |
| Priority date | — |
| Expiry date | Sep 17, 2001 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S530/807
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to novel antigen derivatives comprising an antigen and at least one muramylpeptide covalently bonded thereto, if appropriate via a spacer, to pharmaceutical preparations which contain such compounds and to their use as a vaccine. The novel antigen derivatives produce a pronounced increase in the immuno-response to the antigen, and in particular also a cell-medicated immunity under clinically acceptable conditions of administration.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.